操纵自家股价，上市公司董事长被曝光：最终亏了739万元

Core Viewpoint - Jin Cheng Pharmaceutical's chairman Zhao Yeqing has resigned following an administrative penalty from the China Securities Regulatory Commission for stock manipulation involving the company's shares [1] Group 1: Resignation and Penalty - Zhao Yeqing submitted a written resignation as chairman of Jin Cheng Pharmaceutical [1] - The China Securities Regulatory Commission issued an administrative penalty decision against Zhao Yeqing for stock manipulation [1] Group 2: Details of Stock Manipulation - From August 18, 2017, to February 10, 2020, Zhao Yeqing, along with Wang Zhen and Liu Feng, manipulated Jin Cheng Pharmaceutical's stock [1] - The manipulation involved a group of 104 accounts, with a total buying amount of approximately 2.134 billion yuan and selling amount of about 1.870 billion yuan, resulting in a net loss of 7.392 million yuan [1] - The regulatory authority rejected the defendants' claims of "no manipulative intent" during the investigation [1] Group 3: Consequences - Zhao Yeqing was fined 1.5 million yuan and received a four-year market ban [1]